Acumen Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Acumen Pharmaceuticals stock have an average target of 8.00, which predicts an increase of 225.20% from the current stock price of 2.46.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$8.00	$8.00	$8.00
Change	+225.20%	+225.20%	+225.20%	+225.20%

* Price targets were last updated on Mar 26, 2026.

Analyst Ratings

The average analyst rating for Acumen Pharmaceuticals stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	4	4	4	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Thomas Shrader BTIG	BTIG	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+225.20%	Mar 26, 2026
Thomas Shrader BTIG	BTIG	Strong Buy Maintains $7 → $8	Strong Buy	Maintains	$7 → $8	+225.20%	Mar 16, 2026
Thomas Shrader BTIG	BTIG	Strong Buy Maintains $4 → $7	Strong Buy	Maintains	$4 → $7	+184.55%	Jan 27, 2026
Geoff Meacham B of A Securities	B of A Securities	Strong Buy Maintains $9 → $8	Strong Buy	Maintains	$9 → $8	+225.20%	Nov 18, 2025
Geoff Meacham B of A Securities	B of A Securities	Strong Buy Maintains $10 → $9	Strong Buy	Maintains	$10 → $9	+265.85%	Aug 25, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.45

from -2.00

EPS Next Year

-1.23

from -1.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-5.02	-1.06	-1.08	-1.71	-2.00	-1.45	-1.23
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.29	-1.06
Avg	-1.45	-1.23
Low	-1.59	-1.36

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.